Shilpa Medicare has informed that it enclosed a press release on announcement of commissioning of a state-of-art Antibody–Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals, a material subsidiary of the company. The above information is also available on the website of the Company www.vbshilpa.com.
The above information is a part of company’s filings submitted to BSE.